Fin Trust Capital Advisors, LLC Cara Therapeutics, Inc. Transaction History
Fin Trust Capital Advisors, LLC
- $577 Million
- Q3 2024
A detailed history of Fin Trust Capital Advisors, LLC transactions in Cara Therapeutics, Inc. stock. As of the latest transaction made, Fin Trust Capital Advisors, LLC holds 260 shares of CARA stock, worth $1,279. This represents 0.0% of its overall portfolio holdings.
Number of Shares
260
Previous 260
-0.0%
Holding current value
$1,279
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding CARA
# of Institutions
10Shares Held
826KCall Options Held
0Put Options Held
0-
Black Rock Inc. New York, NY745KShares$3.66 Million0.0% of portfolio
-
American Portfolios Advisors Holbrook, NY40.4KShares$198,8910.02% of portfolio
-
Rathbones Group PLC Liverpool, X020.2KShares$99,2060.0% of portfolio
-
Rothschild Investment Corp10.6KShares$52,1520.0% of portfolio
-
Advisor Group Holdings, Inc. Phoenix, AZ8.83KShares$43,4580.0% of portfolio
About Cara Therapeutics, Inc.
- Ticker CARA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 53,725,900
- Market Cap $264M
- Description
- Cara Therapeutics, Inc., an early commercial-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States. The company is developing product candidates that target the body's peripheral nervous system and...